Ergocalciferol
FDA-approved product (capsule, oral), marketed as Deltalin, Drisdol, Ergocalciferol and 1 more.
- Registered studies
- 50+
- Lab records
- 0
- Pathogens at ≥40%
- 1 of 4
Chemical structure
Existing / approved use
Documented · FDA, WHO, ChEMBLApproved for
- Hypoparathyroidism
- Hypophosphatemia
- Hypophosphatemic rickets
Indications ChEMBL records as approved, from FDA and DailyMed labels. Label ↗
- WHO therapeutic group
- Vitamin d and analogues
- FDA pharmacologic class
- Provitamin D2 Compound FDA label ↗
- Anti-infective classification
- Not classified as an anti-infective.
Repurposing investigation
This medicine is being investigated here for AI-predicted antimicrobial activity against MRSA. It was surfaced computationally for further investigation; it is not an established treatment for this infection.
AI-predicted activity
AI prediction · nothing measured- MRSA46.8% AI-predicted activityAt or above the ≥40% mark this site uses to surface candidates.
- E. coli24.4% AI-predicted activityBelow the ≥40% mark this site uses to surface candidates.
- K. pneumoniae27.9% AI-predicted activityBelow the ≥40% mark this site uses to surface candidates.
- M. tuberculosis30.6% AI-predicted activityBelow the ≥40% mark this site uses to surface candidates.
A model’s estimate of laboratory activity against each pathogen species. It is not clinical effectiveness.
Evidence
Clinical and experimental
Documented evidenceClinical
50+registered studies name this medicine, for any condition. The registry search keeps the first 50, so there may be more. See them below.
Experimental
No evidence found
No laboratory measurement against the four pathogens in the ChEMBL records loaded here.
Docking
Computational · nothing measuredDihydrofolate reductase ↗ (E. coli)
Not yet docked: queued in the docking rundetails
KPC-2 carbapenemase ↗ (K. pneumoniae)
Not yet docked: queued in the docking rundetails
Enoyl-ACP reductase (InhA) ↗ (M. tuberculosis)
Not yet docked: queued in the docking rundetails
Dihydrofolate reductase ↗ (MRSA)
Not yet docked: queued in the docking rundetails
AutoDock Vina, one experimentally solved protein per pathogen. This project’s screening target is -7.0 kcal/mol, its own mark rather than a universal cutoff. A docking score is a structural hypothesis, not proof of binding, and requires experimental validation.
Other medicines to investigate
AI prediction · nothing measuredOther repurposing candidates: approved medicines besides Ergocalciferol with AI-predicted activity ≥40% against the chosen pathogen, leaving out existing antimicrobials. They are computational candidates for further investigation, not alternatives and not recommendations.
Sorted by AI-predicted activity, high to low. The order is not a ranking of which medicine is better.
- FurazolidoneExisting use: Other antiinfectives and antiseptics91.4% AI-predicted activityagainst M. tuberculosisLab records exist49 registered studies
- TriflupromazineExisting use: Psychosis90.6% AI-predicted activityagainst M. tuberculosisNo documented evidence found
- ValdecoxibExisting use: Dysmenorrhea, Osteoarthritis, Rheumatic disease and 1 more88.6% AI-predicted activityagainst M. tuberculosisLab records exist31 registered studies
- CelecoxibExisting use: Ankylosing spondylitis, Cancer, Colorectal neoplasm and 15 more87.6% AI-predicted activityagainst M. tuberculosisLab records exist50+ registered studies
- Dorzolamide HydrochlorideExisting use: Glaucoma, Ocular hypertension, Open-angle glaucoma86.8% AI-predicted activityagainst M. tuberculosisLab records exist50+ registered studies
- MethazolamideExisting use: Glaucoma, Open-angle glaucoma85.6% AI-predicted activityagainst M. tuberculosisLab records exist11 registered studies
- AcetazolamideExisting use: Altitude sickness, Angle-closure glaucoma, Congestive heart failure and 5 more85.2% AI-predicted activityagainst M. tuberculosisLab records exist50+ registered studies
- Trifluoperazine HydrochlorideExisting use: Anxiety disorder, Mental or behavioural disorder, Psychosis and 1 more84.6% AI-predicted activityagainst M. tuberculosis1 registered study
- TriclosanExisting use: Phenol and derivatives, Medicated dressings with antiinfectives84.2% AI-predicted activityagainst M. tuberculosisLab records exist50+ registered studies
- NitrofurazoneExisting use: Eye infection, Leishmaniasis, Trypanosomiasis84.0% AI-predicted activityagainst M. tuberculosis8 registered studies
- BrinzolamideExisting use: Glaucoma, Ocular hypertension, Open-angle glaucoma83.8% AI-predicted activityagainst M. tuberculosisLab records exist50+ registered studies
- ZonisamideExisting use: Epilepsy, Focal-onset seizure, Partial epilepsy and 1 more82.8% AI-predicted activityagainst M. tuberculosisLab records exist50+ registered studies
Registered studies
A registration describes a study; it does not establish a positive result.
Effect of Vitamin D Supplementation on Inflammation and Cardiometabolic Risk Factors in Obese Adolescents
NCT01217840 · start 2010-09
Registered record
- Registry ID
- NCT01217840
- Conditions
- Obesity
- Interventions
- Drisdol (Ergocalciferol) Vitamin D2; Placebo
- Study type
- INTERVENTIONAL
- Phase
- Not applicable
- Registry status
- Completed
- Start
- 2010-09
- Completion
- 2012-08
- Enrolment
- 40
As stored from ClinicalTrials.gov. Registration describes a study; it does not mean the study worked.
ConditionObesityInterventionDrisdol (Ergocalciferol) Vitamin D2; PlaceboPhaseNot applicableRegistry statusCompletedEffects of Ergocalciferol on Erythropoetin Stimulating Agent Dose
NCT01263028 · start 2010-08
Registered record
- Registry ID
- NCT01263028
- Conditions
- Chronic Kidney Disease Stages 3-5
- Interventions
- Ergocalciferol supplementation
- Study type
- INTERVENTIONAL
- Phase
- Not applicable
- Registry status
- Terminated
- Start
- 2010-08
- Completion
- 2011-09
- Enrolment
- 6
As stored from ClinicalTrials.gov. Registration describes a study; it does not mean the study worked.
ConditionChronic Kidney Disease Stages 3-5InterventionErgocalciferol supplementationPhaseNot applicableRegistry statusTerminatedVitamin D Homeostasis in Sarcoidosis
NCT03621553 · start 2010-07-01
Registered record
- Registry ID
- NCT03621553
- Conditions
- Sarcoidosis; Vitamin D Insufficiency
- Interventions
- Ergocalciferol; Placebo; Calcium Citrate with Vitamin D2
- Study type
- INTERVENTIONAL
- Phase
- Phase 4
- Registry status
- Recruiting
- Start
- 2010-07-01
- Completion
- 2026-12-30
- Enrolment
- 90
As stored from ClinicalTrials.gov. Registration describes a study; it does not mean the study worked.
ConditionSarcoidosis; Vitamin D InsufficiencyInterventionErgocalciferol; Placebo; Calcium Citrate with Vitamin D2PhasePhase 4Registry statusRecruitingFeasibility and Effectiveness of Micronutrients as Palliative Care Therapy in Patients With Congestive Heart Failure
NCT01474486 · start 2010-04
Registered record
- Registry ID
- NCT01474486
- Conditions
- Congestive Heart Failure; Ischemic Cardiomyopathy
- Interventions
- Micronutrients
- Study type
- INTERVENTIONAL
- Phase
- Not applicable
- Registry status
- Completed
- Start
- 2010-04
- Completion
- 2016-02
- Enrolment
- 40
As stored from ClinicalTrials.gov. Registration describes a study; it does not mean the study worked.
ConditionCongestive Heart Failure; Ischemic CardiomyopathyInterventionMicronutrientsPhaseNot applicableRegistry statusCompletedIdentification of Markers for Determining the Efficacy of Vitamin D Receptor Activator Therapy in Stage 3/4 CKD Patients
NCT02018133 · start 2009-12
Registered record
- Registry ID
- NCT02018133
- Conditions
- CKD Stage 3/4
- Interventions
- Vitamin D 2mg daily for 2 weeks oral paricalcitol; Placebo
- Study type
- OBSERVATIONAL
- Phase
- Not recorded
- Registry status
- Completed
- Start
- 2009-12
- Completion
- 2012-06
- Enrolment
- 8
As stored from ClinicalTrials.gov. Registration describes a study; it does not mean the study worked.
ConditionCKD Stage 3/4InterventionVitamin D 2mg daily for 2 weeks oral paricalcitol; PlaceboPhaseNot recordedRegistry statusCompletedPhase III Trial of High Dose vs. Standard Dose Vit D2 With Docetaxel in Met Breast ca
NCT00944424 · start 2009-07
Registered record
- Registry ID
- NCT00944424
- Conditions
- Breast Cancer
- Interventions
- Docetaxel + High dose Vitamin D2; Docetaxel + Standard dose Vitamin D2
- Study type
- INTERVENTIONAL
- Phase
- Phase 3
- Registry status
- Unknown
- Start
- 2009-07
- Completion
- 2012-07
- Enrolment
- 260
As stored from ClinicalTrials.gov. Registration describes a study; it does not mean the study worked.
ConditionBreast CancerInterventionDocetaxel + High dose Vitamin D2; Docetaxel + Standard dose Vitamin D2PhasePhase 3Registry statusUnknownCalcium, Vitamin D and Metformin to Treat Insulin Resistance in Obese African American Adolescent Females
NCT01107808 · start 2009-06
Registered record
- Registry ID
- NCT01107808
- Conditions
- Insulin Resistance; Insulin Sensitivity; Obesity; Vitamin D Deficiency
- Interventions
- Calcium and Vit D; Metformin, Vit D and Calcium
- Study type
- INTERVENTIONAL
- Phase
- Not applicable
- Registry status
- Withdrawn
- Start
- 2009-06
- Completion
- 2011-03
- Enrolment
- 0
As stored from ClinicalTrials.gov. Registration describes a study; it does not mean the study worked.
ConditionInsulin Resistance; Insulin Sensitivity; Obesity; Vitamin D DeficiencyInterventionCalcium and Vit D; Metformin, Vit D and CalciumPhaseNot applicableRegistry statusWithdrawnVitamin D, Chronic Kidney Disease (CKD) and the Microcirculation
NCT00882401 · start 2009-04
Registered record
- Registry ID
- NCT00882401
- Conditions
- Chronic Kidney Disease; Vitamin D Deficiency
- Interventions
- Ergocalciferol (Vitamin D); Placebo
- Study type
- INTERVENTIONAL
- Phase
- Phase 4
- Registry status
- Completed
- Start
- 2009-04
- Completion
- 2010-10
- Enrolment
- 64
As stored from ClinicalTrials.gov. Registration describes a study; it does not mean the study worked.
ConditionChronic Kidney Disease; Vitamin D DeficiencyInterventionErgocalciferol (Vitamin D); PlaceboPhasePhase 4Registry statusCompletedTreatment of Vitamin D Deficiency in Patients With Rheumatoid Arthritis
NCT01426347 · start 2009-01
Registered record
- Registry ID
- NCT01426347
- Conditions
- Rheumatoid Arthritis; Vitamin D Deficiency
- Interventions
- Placebo sugar pill; Ergocalciferol
- Study type
- INTERVENTIONAL
- Phase
- Not applicable
- Registry status
- Completed
- Start
- 2009-01
- Completion
- 2012-01
- Enrolment
- 139
As stored from ClinicalTrials.gov. Registration describes a study; it does not mean the study worked.
ConditionRheumatoid Arthritis; Vitamin D DeficiencyInterventionPlacebo sugar pill; ErgocalciferolPhaseNot applicableRegistry statusCompletedThe Efficacy and Safety of Calcitriol for the Treatment of Lupus Nephritis and Persistent Proteinuria
NCT00508898 · start 2008-05
Registered record
- Registry ID
- NCT00508898
- Conditions
- Systemic Lupus Erythematosus; Nephritis; Proteinuria
- Interventions
- Calcitriol; Multivitamin
- Study type
- INTERVENTIONAL
- Phase
- Phase 4
- Registry status
- Withdrawn
- Start
- 2008-05
- Completion
- 2009-09
- Enrolment
- 0
As stored from ClinicalTrials.gov. Registration describes a study; it does not mean the study worked.
ConditionSystemic Lupus Erythematosus; Nephritis; ProteinuriaInterventionCalcitriol; MultivitaminPhasePhase 4Registry statusWithdrawnVitamin D Levels in Children With IBD
NCT00621257 · start 2008-01
Registered record
- Registry ID
- NCT00621257
- Conditions
- Inflammatory Bowel Disease; Crohn's Disease; Ulcerative Colitis
- Interventions
- ergocalciferol; Cholecalciferol
- Study type
- INTERVENTIONAL
- Phase
- Not applicable
- Registry status
- Terminated
- Start
- 2008-01
- Completion
- 2011-03
- Enrolment
- 134
As stored from ClinicalTrials.gov. Registration describes a study; it does not mean the study worked.
ConditionInflammatory Bowel Disease; Crohn's Disease; Ulcerative ColitisInterventionergocalciferol; CholecalciferolPhaseNot applicableRegistry statusTerminatedEffect of Different Vitamin D Vitamers on Vitamin D Status
NCT02860663 · start 2007-08
Registered record
- Registry ID
- NCT02860663
- Conditions
- Vitamin D Status
- Interventions
- Vitamin D3; Vitamin D2; 25OHD
- Study type
- INTERVENTIONAL
- Phase
- Not applicable
- Registry status
- Completed
- Start
- 2007-08
- Completion
- 2008-04
- Enrolment
- 14
As stored from ClinicalTrials.gov. Registration describes a study; it does not mean the study worked.
ConditionVitamin D StatusInterventionVitamin D3; Vitamin D2; 25OHDPhaseNot applicableRegistry statusCompletedhCAP18 Levels and Vitamin D Deficiency in Healthy Subjects
NCT00742235 · start 2007-07
Registered record
- Registry ID
- NCT00742235
- Conditions
- Healthy Subjects; Vitamin D Deficiency
- Interventions
- ergocalciferol
- Study type
- INTERVENTIONAL
- Phase
- Not applicable
- Registry status
- Completed
- Start
- 2007-07
- Completion
- 2012-01
- Enrolment
- 99
As stored from ClinicalTrials.gov. Registration describes a study; it does not mean the study worked.
ConditionHealthy Subjects; Vitamin D DeficiencyInterventionergocalciferolPhaseNot applicableRegistry statusCompletedClinical Approaches to Correcting Vitamin D Inadequacy and Maintaining Adequacy
NCT00692120 · start 2007-02
Registered record
- Registry ID
- NCT00692120
- Conditions
- Vitamin D Inadequacy; Vitamin D Deficiency
- Interventions
- Cholecalciferol (vitamin D3); Ergocalciferol (vitamin D2); Ergocalciferol (vitamin D2); Cholecalciferol (vitamin D3); Placebo
- Study type
- INTERVENTIONAL
- Phase
- Not applicable
- Registry status
- Completed
- Start
- 2007-02
- Completion
- 2008-11
- Enrolment
- 64
As stored from ClinicalTrials.gov. Registration describes a study; it does not mean the study worked.
ConditionVitamin D Inadequacy; Vitamin D DeficiencyInterventionCholecalciferol (vitamin D3); Ergocalciferol (vitamin D2); Ergocalciferol (vitamin D2); Cholecalciferol (vitamin D3) +1 morePhaseNot applicableRegistry statusCompletedVitamin D Deficiency in Elderly African American Women in Central Texas
NCT01971411 · start 2006-03
Registered record
- Registry ID
- NCT01971411
- Conditions
- Vitamin D Deficiency; Osteoporosis; Osteopenia
- Interventions
- Calcium 500mg with 200 IU Vitamin D - 2 tablets daily; Blood levels of Vitamin D, Serum CTX, Mg, Ca++ and iPTH; Usual sun exposure documentation; Dietary intake of calcium, vitamin D, magnesium
- Study type
- OBSERVATIONAL
- Phase
- Not recorded
- Registry status
- Completed
- Start
- 2006-03
- Completion
- 2007-05
- Enrolment
- 60
As stored from ClinicalTrials.gov. Registration describes a study; it does not mean the study worked.
ConditionVitamin D Deficiency; Osteoporosis; OsteopeniaInterventionCalcium 500mg with 200 IU Vitamin D - 2 tablets daily; Blood levels of Vitamin D, Serum CTX, Mg, Ca++ and iPTH; Usual sun exposure documentation; Dietary intake of calcium, vitamin D, magnesiumPhaseNot recordedRegistry statusCompleted